Survivin Inhibitors Mitigate Chemotherapeutic Resistance in Breast Cancer Cells by Suppressing Genotoxic Nuclear Factor-{kappa}B Activation [Drug Discovery and Translational Medicine]

Wang, W., Zhang, B., Mani, A. M., Wu, Z., Fan, Y., Li, W., Wu, Z.-H.
The American Society for Pharmacology and Experimental Therapeutics
Published 2018
Publication Date:
2018-06-09
Publisher:
The American Society for Pharmacology and Experimental Therapeutics
Print ISSN:
0022-3565
Electronic ISSN:
1521-0103
Topics:
Medicine
Published by: